BioSpace News Archive

Increasing requirement for 2-bags, 4-bags and dry plasma thawers from blood banks & hospitals will push sales of blood thawing systems

In accordance with the newsletter that was published the 5th of January 2021, Erik Penser Bank has now begun the implementation of a number of commissioned analyses, the first of which has been published and is available on ChemoTech’s website in English

Metagenomi, a gene editing company, presented preclinical data on three new CRISPR-associated gene editing systems useful for the development of novel cellular therapies, including T- and NK-cell therapies, at the 24th Annual Meeting of the American Society of Gene and Cell Therapy, which is being held virtually.

PharmaEssentia USA Corporation announced the resubmission of its Biologics License Application to the U.S. Food and Drug Administration, seeking approval for ropeginterferon alfa-2b-njft for the treatment of polycythemia vera, a rare blood cancer.

Continued advancement of broad portfolio, highlighted by initiation of Phase 2a dose expansion of Cullinan Pearl in NSCLC patients with EGFRex20ins mutations

Rochester SIT Lab investigates Casana’s new effortless noninvasive in-home health monitoring technologies

SpringWorks Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, announced that management will participate in a Fireside Chat at the Cowen 2nd Annual Oncology Innovation Summit on Friday, May 21st at 10:00AM ET.

National Cancer Institute-designated Sidney Kimmel Cancer Center partners with Caris’ collaborative network of oncology experts to advance personalized cancer treatments

Transparency Market Research has published a new report on the home blood pressure monitoring devices market for the forecast period of 2019–2027.

Growing population of younger diabetic patients is one of the key factors driving sales of diabetes management software